Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 75

1.

Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo.

Fishman S, Muzumdar RH, Atzmon G, Ma X, Yang X, Einstein FH, Barzilai N.

FASEB J. 2007 Jan;21(1):53-60. Epub 2006 Nov 10.

PMID:
17099068
[PubMed - indexed for MEDLINE]
Free Article
2.

Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?

Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH, Scherer P, Rossetti L, Barzilai N.

Diabetes. 2002 Oct;51(10):2951-8.

PMID:
12351432
[PubMed - indexed for MEDLINE]
Free Article
3.

Perinephric and epididymal fat affect hepatic metabolism in rats.

Ben-Shlomo S, Einstein FH, Zvibel I, Atias D, Shlomai A, Halpern Z, Barzilai N, Fishman S.

Obesity (Silver Spring). 2012 Jan;20(1):151-6. doi: 10.1038/oby.2011.261. Epub 2011 Aug 4.

PMID:
21818154
[PubMed - indexed for MEDLINE]
4.

Accretion of visceral fat and hepatic insulin resistance in pregnant rats.

Einstein FH, Fishman S, Muzumdar RH, Yang XM, Atzmon G, Barzilai N.

Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E451-5. Epub 2007 Dec 11.

PMID:
18073320
[PubMed - indexed for MEDLINE]
Free Article
5.

The regulation of body fat distribution and the modulation of insulin action.

Cases JA, Barzilai N.

Int J Obes Relat Metab Disord. 2000 Nov;24 Suppl 4:S63-6. Review.

PMID:
11126245
[PubMed - indexed for MEDLINE]
6.

Interaction between aging and syndrome X: new insights on the pathophysiology of fat distribution.

Barzilai N, Gupta G.

Ann N Y Acad Sci. 1999 Nov 18;892:58-72. Review.

PMID:
10842652
[PubMed - indexed for MEDLINE]
7.

Surgical removal of visceral fat reverses hepatic insulin resistance.

Barzilai N, She L, Liu BQ, Vuguin P, Cohen P, Wang J, Rossetti L.

Diabetes. 1999 Jan;48(1):94-8.

PMID:
9892227
[PubMed - indexed for MEDLINE]
8.

Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity.

Koyama K, Chen G, Lee Y, Unger RH.

Am J Physiol. 1997 Oct;273(4 Pt 1):E708-13.

PMID:
9357799
[PubMed - indexed for MEDLINE]
9.

Liver triglyceride secretion and lipid oxidative metabolism are rapidly altered by leptin in vivo.

Huang W, Dedousis N, Bandi A, Lopaschuk GD, O'Doherty RM.

Endocrinology. 2006 Mar;147(3):1480-7. Epub 2005 Dec 8.

PMID:
16339207
[PubMed - indexed for MEDLINE]
10.

Hepatic triglyceride synthesis and nonalcoholic fatty liver disease.

Choi SS, Diehl AM.

Curr Opin Lipidol. 2008 Jun;19(3):295-300. doi: 10.1097/MOL.0b013e3282ff5e55. Review.

PMID:
18460922
[PubMed - indexed for MEDLINE]
11.

Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models.

den Boer M, Voshol PJ, Kuipers F, Havekes LM, Romijn JA.

Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):644-9. Epub 2004 Jan 8. Review.

PMID:
14715643
[PubMed - indexed for MEDLINE]
Free Article
12.

Impaired activation of phosphatidylinositol 3-kinase by leptin is a novel mechanism of hepatic leptin resistance in diet-induced obesity.

Huang W, Dedousis N, Bhatt BA, O'Doherty RM.

J Biol Chem. 2004 May 21;279(21):21695-700. Epub 2004 Mar 1.

PMID:
14993225
[PubMed - indexed for MEDLINE]
Free Article
13.

Ability of insulin to modulate hepatic glucose production in aging rats is impaired by fat accumulation.

Gupta G, Cases JA, She L, Ma XH, Yang XM, Hu M, Wu J, Rossetti L, Barzilai N.

Am J Physiol Endocrinol Metab. 2000 Jun;278(6):E985-91.

PMID:
10826999
[PubMed - indexed for MEDLINE]
Free Article
14.

Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats.

Oakes ND, Thalén P, Hultstrand T, Jacinto S, Camejo G, Wallin B, Ljung B.

Am J Physiol Regul Integr Comp Physiol. 2005 Oct;289(4):R938-46.

PMID:
16183630
[PubMed - indexed for MEDLINE]
Free Article
15.

Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat.

Barzilai N, Banerjee S, Hawkins M, Chen W, Rossetti L.

J Clin Invest. 1998 Apr 1;101(7):1353-61.

PMID:
9525977
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Lipase maturation factor 1: its expression in Zucker diabetic rats, and effects of metformin and fenofibrate.

Forcheron F, Basset A, Del Carmine P, Beylot M.

Diabetes Metab. 2009 Dec;35(6):452-7. doi: 10.1016/j.diabet.2009.05.004. Epub .

PMID:
19854668
[PubMed - indexed for MEDLINE]
Free Article
17.

Hepatic steatosis and plasma dyslipidemia induced by a high-sucrose diet are corrected by an acute leptin infusion.

Huang W, Dedousis N, O'Doherty RM.

J Appl Physiol (1985). 2007 Jun;102(6):2260-5. Epub 2007 Mar 15.

PMID:
17363621
[PubMed - indexed for MEDLINE]
Free Article
18.

[Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats].

Ran JM, Lao GC, Xu G, Xie B, Zhang Y, Liu W, Feng Q, Guo J.

Zhonghua Yi Xue Za Zhi. 2008 Jun 10;88(22):1557-61. Chinese.

PMID:
18956640
[PubMed - indexed for MEDLINE]
19.

Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.

Upton R, Widdowson PS, Ishii S, Tanaka H, Williams G.

Br J Pharmacol. 1998 Dec;125(8):1708-14.

PMID:
9886762
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Tissue-specific postprandial clearance is the major determinant of PPARgamma-induced triglyceride lowering in the rat.

Laplante M, Festuccia WT, Soucy G, Blanchard PG, Renaud A, Berger JP, Olivecrona G, Deshaies Y.

Am J Physiol Regul Integr Comp Physiol. 2009 Jan;296(1):R57-66. doi: 10.1152/ajpregu.90552.2008. Epub 2008 Oct 29.

PMID:
18971352
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk